These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 32681501

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. CRISPR/Cas9-mediated genome editing efficiently creates specific mutations at multiple loci using one sgRNA in Brassica napus.
    Yang H, Wu JJ, Tang T, Liu KD, Dai C.
    Sci Rep; 2017 Aug 08; 7(1):7489. PubMed ID: 28790350
    [Abstract] [Full Text] [Related]

  • 25. Effective knockdown of Drosophila long non-coding RNAs by CRISPR interference.
    Ghosh S, Tibbit C, Liu JL.
    Nucleic Acids Res; 2016 May 19; 44(9):e84. PubMed ID: 26850642
    [Abstract] [Full Text] [Related]

  • 26. Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening.
    Esposito R, Bosch N, Lanzós A, Polidori T, Pulido-Quetglas C, Johnson R.
    Cancer Cell; 2019 Apr 15; 35(4):545-557. PubMed ID: 30827888
    [Abstract] [Full Text] [Related]

  • 27. Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems.
    Filippova J, Matveeva A, Zhuravlev E, Stepanov G.
    Biochimie; 2019 Dec 15; 167():49-60. PubMed ID: 31493470
    [Abstract] [Full Text] [Related]

  • 28. Development of a gRNA Expression and Processing Platform for Efficient CRISPR-Cas9-Based Gene Editing and Gene Silencing in Candida tropicalis.
    Li Y, Zhang L, Yang H, Xia Y, Liu L, Chen X, Shen W.
    Microbiol Spectr; 2022 Jun 29; 10(3):e0005922. PubMed ID: 35543560
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance.
    Babu K, Amrani N, Jiang W, Yogesha SD, Nguyen R, Qin PZ, Rajan R.
    Biochemistry; 2019 Apr 09; 58(14):1905-1917. PubMed ID: 30916546
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inconclusive studies on possible CRISPR-Cas off-targets should moderate expectations about enzymes that have evolved to be non-specific.
    Chakraborty S.
    J Biosci; 2018 Jun 09; 43(2):225-228. PubMed ID: 29872009
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.
    Lattanzi A, Meneghini V, Pavani G, Amor F, Ramadier S, Felix T, Antoniani C, Masson C, Alibeu O, Lee C, Porteus MH, Bao G, Amendola M, Mavilio F, Miccio A.
    Mol Ther; 2019 Jan 02; 27(1):137-150. PubMed ID: 30424953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.